High Priority Alert

We are experiencing extremely high demand in our Emergency Department. Learn more.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines. Learn more.

Center for Integrative Brain Research
Back to... ➝
Donate Now
Grill Lab Menu
Back to... ➝
Donate Now
Welcome to the Grill Lab

Grill Lab

The Grill Lab’s overarching interest is in using in vivo proteomic and genetic approaches to understand how signaling influences development and function of the nervous system.

Progress on these research directions is essential to understanding how the nervous system is built and modulated. Ultimately, we strive to identify new molecular targets for treating neurodevelopmental disorders, neurodegenerative disease and opioid addiction/withdrawal. 

Our work is made possible in part by a generous gift in honor of Timothy Jackson.

Projects

Proteomic and Genetic Insight Into Axon Termination, Synapse Maintenance and Autophagy

We are leading efforts to understand a conserved signaling network required for both axon termination and synapse maintenance.
Using Forward Genetics to Identify Regulators of Opioid Sensitivity and Tolerance

We have spent the past decade pioneering an innovative new line of investigation that aims to understand how u-opioid receptor (MOR) signaling, sensitivity and tolerance are regulated.
Regulation of Inhibitory GABA Neuron Function

Our interest in HUWE1 is driven on two levels. 1) Better understanding how ubiquitin ligase activity shapes inhibitory GABA neuron function. 2) Strong, growing evidence that human genetic changes that reduce or increase HUWE1 function result in syndromic and non-syndromic forms of intellectual disability.

Latest News

Sleuthing the Source of a New Neurodevelopmental Disorder

Oct. 6, 2022 – Dr. Brock Grill and his lab members in the Center for Integrative Brain Research collaborated with an international research team to identify the molecular genetic cause of a new neurodevelopmental disorder.

Identifying genetic regulators of opioid tolerance

Aug. 18, 2022 - Nature Neuroscience published new insights by SCRI’s Dr. Brock Grill and UF Scripps Biomedical Research’s Dr. Kirill Martemyanov into a molecular genetic mechanism that affects tolerance at the behavioral level.

Join Us!

We are always recruiting postdocs and graduate students. Contact the Grill Lab.

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

 Accept All Cookies